REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $485 | -37.7% | 4,761 | -44.4% | 0.00% | -55.6% |
Q1 2023 | $778 | +194.7% | 8,558 | +23.1% | 0.01% | +200.0% |
Q4 2022 | $264 | -99.9% | 6,952 | -13.8% | 0.00% | 0.0% |
Q3 2022 | $203,000 | -25.6% | 8,067 | -10.1% | 0.00% | 0.0% |
Q2 2022 | $273,000 | +108.4% | 8,976 | +80.2% | 0.00% | +200.0% |
Q4 2021 | $131,000 | -90.4% | 4,981 | -63.3% | 0.00% | -83.3% |
Q3 2021 | $1,364,000 | +171.7% | 13,561 | +282.4% | 0.01% | +200.0% |
Q2 2021 | $502,000 | +160.1% | 3,546 | +83.6% | 0.00% | +100.0% |
Q1 2021 | $193,000 | -85.5% | 1,931 | -82.0% | 0.00% | -85.7% |
Q4 2020 | $1,327,000 | +57.0% | 10,736 | +23.8% | 0.01% | +40.0% |
Q3 2020 | $845,000 | +46.2% | 8,675 | +134.2% | 0.01% | 0.0% |
Q2 2020 | $578,000 | -30.4% | 3,704 | -35.6% | 0.01% | -37.5% |
Q1 2020 | $830,000 | +49.5% | 5,750 | +111.7% | 0.01% | +60.0% |
Q4 2019 | $555,000 | +130.3% | 2,716 | +6.4% | 0.01% | +150.0% |
Q2 2019 | $241,000 | -4.0% | 2,553 | -13.0% | 0.00% | 0.0% |
Q1 2019 | $251,000 | +46.8% | 2,936 | -4.0% | 0.00% | +100.0% |
Q4 2018 | $171,000 | – | 3,057 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |